| http://www.w3.org/ns/prov#value | - Actual results or events could differ materially from the plans, intentions and expectations expressed or implied in any forward looking statements, including the underlying assumptions thereto, as a result of numerous risks, uncertainties and other factors including: Genzyme may not have the ability to increase its offer to acquire all outstanding shares of AnorMED for US $13.50 per share in cash
|
